Tibet Rhodiola Pharmaceutical Holding Co (600211) — Cash Flow Reinvestment Rate
Tibet Rhodiola Pharmaceutical Holding Co (600211) has a Cash Flow Reinvestment Rate of 0.07x as of December 2025, reinvesting CN¥20.26 Million (capex CN¥4.98 Million plus investments CN¥15.27 Million) from operating cash flow of CN¥297.86 Million. See free cash flow generation of Tibet Rhodiola Pharmaceutical Holding Co to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tibet Rhodiola Pharmaceutical Holding Co Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Tibet Rhodiola Pharmaceutical Holding Co across 25 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Tibet Rhodiola Pharmaceutical Holding Co.
Annual Cash Flow Reinvestment Rate for Tibet Rhodiola Pharmaceutical Holding Co (1999–2025)
Year-by-year capital reinvestment analysis for Tibet Rhodiola Pharmaceutical Holding Co. See Tibet Rhodiola Pharmaceutical Holding Co financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.73x | CN¥751.90 Million | CN¥1.03 Billion | CN¥15.96 Million | ▲ +70.7% |
| 2024 | 0.43x | CN¥426.90 Million | CN¥994.79 Million | CN¥37.60 Million | ▼ -45.6% |
| 2023 | 0.79x | CN¥853.57 Million | CN¥1.08 Billion | CN¥21.69 Million | ▲ +15.1% |
| 2022 | 0.69x | CN¥573.65 Million | CN¥837.38 Million | CN¥101.96 Million | ▼ -67.0% |
| 2021 | 2.08x | CN¥760.55 Million | CN¥366.53 Million | CN¥425.58 Million | ▲ +77.2% |
| 2020 | 1.17x | CN¥501.29 Million | CN¥428.17 Million | CN¥221.29 Million | ▲ +150.3% |
| 2019 | 0.47x | CN¥229.00 Million | CN¥489.59 Million | CN¥49.00 Million | ▼ -33.5% |
| 2018 | 0.70x | CN¥203.37 Million | CN¥289.22 Million | CN¥23.37 Million | ▼ -90.5% |
| 2017 | 7.41x | CN¥677.98 Million | CN¥91.46 Million | CN¥607.98 Million | ▲ +446.0% |
| 2016 | 1.36x | CN¥339.72 Million | CN¥250.21 Million | CN¥9.64 Million | ▼ -41.8% |
| 2015 | 2.33x | CN¥312.46 Million | CN¥133.93 Million | CN¥10.66 Million | ▲ +1809.4% |
| 2013 | 0.12x | CN¥34.12 Million | CN¥279.22 Million | CN¥34.12 Million | ▲ +55.4% |
| 2012 | 0.08x | CN¥4.42 Million | CN¥56.20 Million | CN¥4.42 Million | ▼ -58.9% |
| 2011 | 0.19x | CN¥2.31 Million | CN¥12.09 Million | CN¥2.31 Million | ▼ -85.9% |
| 2010 | 1.36x | CN¥2.58 Million | CN¥1.90 Million | CN¥2.58 Million | ▲ +555.4% |
| 2009 | 0.21x | CN¥3.70 Million | CN¥17.88 Million | CN¥3.70 Million | ▼ -7.5% |
| 2008 | 0.22x | CN¥4.80 Million | CN¥21.46 Million | CN¥4.80 Million | ▼ -52.7% |
| 2006 | 0.47x | CN¥15.90 Million | CN¥33.63 Million | CN¥15.90 Million | ▲ +26.5% |
| 2005 | 0.37x | CN¥7.07 Million | CN¥18.92 Million | CN¥7.07 Million | ▼ -42.4% |
| 2004 | 0.65x | CN¥17.45 Million | CN¥26.90 Million | CN¥17.45 Million | ▲ +33.8% |
| 2003 | 0.48x | CN¥22.88 Million | CN¥47.20 Million | CN¥22.88 Million | ▼ -84.4% |
| 2002 | 3.11x | CN¥102.14 Million | CN¥32.85 Million | CN¥102.14 Million | ▼ -39.7% |
| 2001 | 5.15x | CN¥79.72 Million | CN¥15.47 Million | CN¥79.72 Million | ▼ -10.6% |
| 2000 | 5.76x | CN¥118.45 Million | CN¥20.55 Million | CN¥118.45 Million | ▼ -79.5% |
| 1999 | 28.15x | CN¥63.25 Million | CN¥2.25 Million | CN¥63.25 Million | — |